Loading organizations...
§ Private Profile · Milan, Lombardia, Italy
Medical device startup developing percutaneous tricuspid valve repair systems for tricuspid regurgitation, focused on minimally invasive treatment.
Approxima is a medical device company based in Milan, Italy, developing a proprietary percutaneous tricuspid valve repair system to treat tricuspid regurgitation through right ventricular reshaping. The preclinical enterprise engineers minimally invasive cardiovascular technologies designed as direct alternatives to high risk open heart surgeries for a structural heart disease market valued at over five billion euros. To support ongoing research and regulatory approvals, the startup has raised nearly nine million euros in equity financing, including a seed round and a Series A first close of seven million three hundred thousand euros in February 2025. This venture capital backing includes strategic investments from institutional entities like Panakès Partners, ENEA Tech & Biomedical, and Club degli Investitori. Approxima was founded in 2020 as a spinout from Politecnico di Milano by Michal Jaworek, Edoardo Maroncelli, Riccardo Vismara, and Gianfranco Beniamino Fiore.
Approxima has raised $1.8M across 1 funding round.
Approxima has raised $1.8M in total across 1 funding round.
Approxima has raised $1.8M in total across 1 funding round.
Approxima's investors include Panakes Partners, Club degli Investitori.
Approxima has raised $1.8M across 1 funding round. Most recently, it raised $1.8M Seed in July 2023.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jul 14, 2023 | $1.8M Seed | Panakes Partners | Club Degli Investitori | Announced |